----

| ☒ | QUARTERLY REPORT UNDER TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2016 |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|
| OR      |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934                                               |
| Large Accelerated Filer                                              | ☐ |   | Accelerated Filer         | ☐ |
|----------------------------------------------------------------------|---------|--------|---------------------------|---------|
| Non-accelerated Filer                                                | ☐ |   | Smaller Reporting Company | ☒ |
| Emerging Growth Company*(Do not check if smaller reporting company)* | ☐ |   |                      |    |

----

----

Table of Contents

|          | PAGE                                                                                  |
|---------------|---------------------------------------------------------------------------------------|
|          |                                                                                  |
| PART I        | 3                                                                                     |
|          |                                                                                  |
| Item 1.       | Financial Statements.                                                                 | 3 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Balance Sheets                                                 | 3 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Statements Of Operations                                       | 4 |
|          |                                                                                  |   |
|          | Unaudited Consolidated Statements Of Cash Flows                                       | 5 |
|          |                                                                                  |   |
|          | Notes to Unaudited Consolidated Financial Statements                                  | 6 |
|          |                                                                                  |   |
| Item 2.       | Management's Discussion and Analysis of Financial Condition and Results ofOperations. | 12 |
|          |                                                                                  |   |
| Item 3.       | Quantitative and Qualitative Disclosures about Market Risk.                           | 16 |
|          |                                                                                  |   |
| Item 4.       | Controls and Procedures.                                                              | 16 |
|          |                                                                                  |   |
| PART II       | 16                                                                                    |
|          |                                                                                  |
| Item 1.       | Legal Proceedings.                                                                    | 16 |
|          |                                                                                  |   |
| Item 1A.      | Risk Factors.                                                                         | 16 |
|          |                                                                                  |   |
| Item 6.       | Exhibits.                                                                             | 17 |
|          |                                                                                  |   |
| Signatures    | 19                                                                                    |
|          |                                                                                  |
| Exhibit Index | 20                                                                                    |

----

Table of Contents

| ITEM 1. | FINANCIAL STATEMENTS. |
|---------|-----------------------|

|                                                                                                                                          |   | September 30,2016 |        |   | December 31,2015 |   |
|-----------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------|-------------|--------|------------------|--------|
| ASSETS                                                                                                                                        |   |              |        |   |             |   |
| Current Assets:                                                                                                                               |   |              |        |   |             |   |
| Cash                                                                                                                                          |   | $                 | 211         |   |             | $      | 4,998 |   |
| Prepaid expenses                                                                                                                              |   |              | 101,045     |   |             |   | 132,259 |   |
| Total Current Assets                                                                                                                          |   |              | 101,256     |   |             |   | 137,257 |   |
|                                                                                                                                          |   |              |        |   |             |   |   |   |
| Deposit – long term                                                                                                                     |   |              | -           |   |             |   | 20,627 |   |
| Equipment, net                                                                                                                                |   |              | -           |   |             |   | 135,551 |   |
| TOTAL ASSETS                                                                                                                                  |   | $                 | 101,256     |   |             | $      | 293,435 |   |
|                                                                                                                                          |   |              |        |   |             |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                      |   |              |        |   |             |   |   |   |
| Current Liabilities:                                                                                                                          |   |              |        |   |             |   |   |   |
| Accounts payable and accrued liabilities                                                                                                      |   | $                 | 2,534,797   |   |             | $      | 1,204,942 |   |
| Derivative liabilities                                                                                                                        |   |              | 210,295     |   |             |   | 210,834 |   |
| Convertible promissory notes, net of discount of $21,634 and $69,568respectively                                                              |   |              | 286,182     |   |             |   | 204,826 |   |
| Convertible loans payable – third parties                                                                                               |   |              | 189,599     |   |             |   | 105,395 |   |
| Short term loans payable                                                                                                                      |   |              | 16,599      |   |             |   | 15,730 |   |
| Convertible loans payable – related parties                                                                                             |   |              | 608,683     |   |             |   | 272,712 |   |
| Deferred lease inducement                                                                                                                     |   |              | 5,043       |   |             |   | 15,380 |   |
| Total Current Liabilities                                                                                                                     |   |              | 3,851,198   |   |             |   | 2,029,819 |   |
| Convertible promissory notes, net of discount of $Nil and $59,939respectively                                                                 |   |              | -           |   |             |   | 24,551 |   |
| TOTAL LIABILITIES                                                                                                                             |   |              | 3,851,198   |   |             |   | 2,054,370 |   |
|                                                                                                                                          |   |              |        |   |             |   |   |   |
| Commitments and Contingencies                                                                                                                 |   |              |        |   |             |   |   |   |
|                                                                                                                                          |   |              |        |   |             |   |   |   |
| Stockholders' Deficiency                                                                                                                      |   |              |        |   |             |   |   |   |
| Preferred stock, $0.00001 par value, 100,000,000 shares authorized,95,000,000 Series A preferred shares issued and outstanding                |   |              | 950         |   |             |   | 950 |   |
| Common stock, $0.00001 par value, 15,000,000,000 shares authorized,8,098,742,772 and 5,648,390,746 shares issued and outstanding,respectively |   |              | 80,988      |   |             |   | 56,485 |   |
| Additional paid-in capital                                                                                                                    |   |              | 30,965,822  |   |             |   | 30,324,674 |   |
| Accumulated deficit                                                                                                                           |   |              | (34,797,702 | )      |             |   | (32,143,044 | ) |
|                                                                                                                                          |   |              |        |   |             |   |   |   |
| Total Stockholders' Deficiency                                                                                                                |   |              | (3,749,942  | )      |             |   | (1,760,935 | ) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY                                                                                                |   | $                 | 101,256     |   |             | $      | 293,435 |   |

----

Table of Contents

|                                                                             |   | Three Months EndedSeptember 30, |          |   | Nine months EndedSeptember 30, |   |
|----------------------------------------------------------------------------------|--------|---------------------------------|---------------|--------|--------------------------------|--------|
|                                                                             |   | 2016                            |          |   | 2015                           |   |   | 2016 |   |   | 2015 |   |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |
| Operating Expenses                                                               |   |                            |          |   |                           |   |   |   |   |   |   |   |
| General and administration                                                       |   | $                               | 426,880       |   |                           | $      | 843,232 |   |   | $ | 2,109,138 |   |   | $ | 6,388,992 |   |
| Selling and marketing                                                            |   |                            | 456           |   |                           |   | 71,224 |   |   |   | 25,080 |   |   |   | 194,773 |   |
| Impairment of assets                                                             |   |                            | -             |   |                           |   | - |   |   |   | 104,018 |   |   |   | - |   |
| Depreciation                                                                     |   |                            | -             |   |                           |   | 15,496 |   |   |   | 31,533 |   |   |   | 35,850 |   |
| Operating loss                                                                   |   |                            | (427,336      | )      |                           |   | (929,952 | ) |   |   | (2,269,769 | ) |   |   | (6,619,615 | ) |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
| Interest and financing costs                                                     |   |                            | (64,501       | )      |                           |   | (394,387 | ) |   |   | (258,720 | ) |   |   | (816,330 | ) |
| Change in fair value of derivative liabilities                                   |   |                            | 57,778        |   |                           |   | 26,625 |   |   |   | (87,684 | ) |   |   | 54,792 |   |
| Foreign exchange (loss) gain                                                     |   |                            | 39,663        |   |                           |   | 1,457 |   |   |   | (38,485 | ) |   |   | 18,547 |   |
| Loss on extinguishment of short term loan payableand convertible promissory note |   |                            | -             |   |                           |   | - |   |   |   | - |   |   |   | (83,344 | ) |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
| Net loss                                                                         |   | $                               | (394,396      | )      |                           | $      | (1,296,257 | ) |   | $ | (2,654,658 | ) |   | $ | (7,445,950 | ) |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per share                                             |   | $                               | (0.00         | )      |                           | $      | (0.00 | ) |   | $ | (0.00 | ) |   | $ | (0.02 | ) |
|                                                                             |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
| Weighted average shares used in calculating                                      |   |                            |          |   |                           |   |   |   |   |   |   |   |   |   |   |   |
| Basic and diluted net loss per share                                             |   |                            | 8,098,742,772 |   |                           |   | 607,936,690 |   |   |   | 7,366,923,856 |   |   |   | 473,124,235 |   |

----

Table of Contents

|                                                                                     |   | Nine months EndedSeptember 30, |       |
|------------------------------------------------------------------------------------------|--------|--------------------------------|------------|
|                                                                                     |   | 2016                           |       |   | 2015 |   |
|                                                                                     |   |                           |       |   |   |   |
| CASH FLOWS FROM OPERATING ACTIVITIES                                                     |   |                           |       |   |   |   |
| Net Loss                                                                                 |   | $                              | (2,654,658 | ) |   | $ | (7,445,950 | ) |
| Adjustment to reconcile net loss to cash used in operating activities:                   |   |                           |       |   |   |   |   |   |
| Depreciation                                                                             |   |                           | 31,533     |   |   |   | 35,850 |   |
| Stock based compensation                                                                 |   |                           | 448,500    |   |   |   | 3,414,000 |   |
| (Gain) Loss on extinguishment of short term loan payable and convertible promissory note |   |                           | -          |   |   |   | 83,344 |   |
| Non cash consulting fees                                                                 |   |                           | -          |   |   |   | 230,739 |   |
| Change in fair value of derivative liabilities                                           |   |                           | 87,684     |   |   |   | (54,792 | ) |
| Impairment of assets                                                                     |   |                           | 104,018    |   |   |   | - |   |
| Interest and penalties                                                                   |   |                           | 149,179    |   |   |   | 23,100 |   |
| Deferred lease inducement                                                                |   |                           | (10,337    | ) |   |   | (15,547 | ) |
| Amortization of debt discount                                                            |   |                           | 107,873    |   |   |   | 776,005 |   |
| Unrealized foreign exchange loss                                                         |   |                           | 26,058     |   |   |   | (33,007 | ) |
| Changes in operating assets and liabilities:                                             |   |                           |       |   |   |   |   |   |
| Decrease (increase) in other receivables                                                 |   |                           | -          |   |   |   | 11,531 |   |
| (Increase) decrease in prepaid expenses and deposit                                      |   |                           | 51,841     |   |   |   | 31,469 |   |
| Decrease in deferred project costs                                                       |   |                           | -          |   |   |   | 24,990 |   |
| (Decrease) in deferred revenue                                                           |   |                           | -          |   |   |   | (24,990 | ) |
| Increase (decrease) in accounts payable and accrued liabilities                          |   |                           | 1,329,848  |   |   |   | (213,500 | ) |
| NET CASH USED IN OPERATING ACTIVITIES                                                    |   |                           | (328,461   | ) |   |   | (3,156,758 | ) |
|                                                                                     |   |                           |       |   |   |   |   |   |
| CASH FLOWS FROM INVESTING ACTIVITY                                                       |   |                           |       |   |   |   |   |   |
| Purchase of equipment                                                                    |   |                           | -          |   |   |   | (258,383 | ) |
| NET CASH USED IN INVESTING ACTIVITY                                                      |   |                           | -          |   |   |   | (258,383 | ) |
|                                                                                     |   |                           |       |   |   |   |   |   |
|                                                                                     |   |                           |       |   |   |   |   |   |
| CASH FLOWS FROM FINANCING ACTIVITIES                                                     |   |                           |       |   |   |   |   |   |
| Proceeds from issuance of common stock                                                   |   |                           | -          |   |   |   | 2,663,273 |   |
| Proceeds from convertible promissory notes                                               |   |                           | -          |   |   |   | 580,075 |   |
| Proceeds from other convertible notes ($268,311 from related parties)                    |   |                           | 323,667    |   |   |   | - |   |
| Repayment of loans payable                                                               |   |                           | -          |   |   |   | (53,540 | ) |
| NET CASH PROVIDED BY FINANCING ACTIVITIES                                                |   |                           | 323,667    |   |   |   | 3,189,808 |   |
|                                                                                     |   |                           |       |   |   |   |   |   |
| Effect of exchange rate changes on cash                                                  |   |                           | 7          |   |   |   | 2,868 |   |
|                                                                                     |   |                           |       |   |   |   |   |   |
| NET DECREASE IN CASH                                                                     |   |                           | (4,787     | ) |   |   | (222,465 | ) |
| CASH - BEGINNING OF PERIOD                                                               |   |                           | 4,998      |   |   |   | 250,339 |   |
| CASH - END OF PERIOD                                                                     |   | $                              | 211        |   |   | $ | 27,874 |   |
| SUPPLEMENTAL CASH FLOW INFORMATION                                                       |   |                           |       |   |   |   |   |   |
| Income tax paid                                                                          |   | $                              | -          |   |   | $ | - |   |
| Interest paid                                                                            |   | $                              | -          |   |   | $ | - |   |
| SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES                     |   |                           |       |   |   |   |   |   |
| Conversion of promissory notes into common shares                                        |   | $                              | 217,151    |   |   | $ | 897,937 |   |
| Convertible loan payable for expenses paid directly by lender                            |   | $                              | 5,434      |   |   | $ | - |   |
| Initial debt discount on convertible promissory notes                                    |   | $                              | -          |   |   | $ | 614,064 |   |
| Accounts payable for equipment                                                           |   | $                              | -          |   |   | $ | 210,892 |   |
| Stock issued for settlement of accounts payable                                          |   | $                              | -          |   |   | $ | 171,362 |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

| Face amount                 |   | Interest rate |   | Due date | Conversion price per share |
|-----------------------------|--------|---------------|--------|----------|----------------------------|
|                        |   |          |   |     |        |
| Promissory note of $100,000 |   |          | 10%    |     | December 21, 2015          | 65% of lowest trading day over the last 15 trading days |
| Promissory note of $50,000  |   |          | 8%     |     | October 5, 2015            | 60% of the lowest trading price over the last 15 trading days |
| Promissory note of $87,500  |   |          | 8%     |     | January 15, 2016           | 70% of average of two lowest closing bid price over the last 15 trading days |
| Promissory note of $55,000  |   |          | 8%     |     | February 11, 2016          | 60% of the lowest trading price over the last 15 trading days |
| Promissory note of $50,000  |   |          | 12%    |     | February 3, 2017           | 65% of the lowest trading price over the last 25 trading days |
| Promissory note of $50,000  |   |          | 8%     |     | June 8, 2017               | 65% of the lowest trading price over the last 20 trading days |
|                                                       |   | September 30,2016 |    |
|------------------------------------------------------------|--------|-------------------|---------|
| Fair value as at Beginning of Period                       |   | $                 | 210,834 |   |
| New promissory notes                                       |   |              | -       |   |
| Elimination associated with conversion of promissory notes |   |              | (88,223 | ) |
| Change in fair value loss (gain)                           |   |              | 87,684  |   |
| Fair value as at End of Period                             |   | $                 | 210,295 |   |

----

Table of Contents

|                                 |   | September 30,2016 |     |   | September 30,2015 |   |
|--------------------------------------|--------|-------------------|----------|--------|-------------------|--------|
|                                 |   |              |     |   |              |   |
| Balance as at Beginning of Period    |   | $                 | 229,377  |   |              | $      | 16,175 |   |
| New convertible promissory notes     |   |              | -        |   |              |   | 633,611 |   |
| Original issue discount              |   |              | -        |   |              |   | (53,536 | ) |
| Interest and Penalties               |   |              | 77,860   |   |              |   | - |   |
| Discount on penalties                |   |              | -        |   |              |   | (20,000 | ) |
| Derivative liabilities               |   |              | -        |   |              |   | (587,510 | ) |
| Converted into shares                |   |              | (128,928 | )      |              |   | (443,659 | ) |
| Amortization of debt discount        |   |              | 107,873  |   |              |   | 776,005 |   |
| Balance as at End of Period          |   | $                 | 286,182  |   |              | $      | 321,086 |   |
| Convertible notes – short term |   |              | (286,182 | )      |              |   | (296,535 | ) |
| Convertible notes – long term  |   | $                 | -        |   |              | $      | 24,551 |   |
| September 30, 2016     |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total   |   |
|------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|---------|--------|
| Liabilities:           |   |    |   |   |    |   |   |    |   |   |    |   |
| Derivative liabilities |   | $       | -      |   |    | $      | -      |    |   | $      | 210,295 |   |   | $ | 210,295 |   |
| December 31, 2015      |   | Level 1 |   |   | Level 2 |   |   | Level 3 |   |   | Total   |   |
|------------------------|--------|---------|--------|--------|---------|--------|--------|---------|--------|--------|---------|--------|
| Liabilities:           |   |    |   |   |    |   |   |    |   |   |    |   |
| Derivative liabilities |   | $       | -      |   |    | $      | -      |    |   | $      | 210,834 |   |   | $ | 210,834 |   |

|                                                                                   |   | September 30,2016 |    |   | December 31,2015 |   |
|----------------------------------------------------------------------------------------|--------|-------------------|---------|--------|------------------|--------|
|                                                                                   |   |              |    |   |             |   |
| Convertible promissory notes bearing interest at 15% per annum – third party     |   | $                 | 189,599 |   |             | $      | 105,395 |   |
| Convertible promissory notes bearing interest at 15% per annum – related parties |   |              | 608,683 |   |             |   | 272,712 |   |
|                                                                                   |   | $                 | 798,282 |   |             | $      | 378,107 |   |

----

Table of Contents

|                                                       |   | September 30,2016 |   |   | December 31,2015 |   |
|------------------------------------------------------------|--------|-------------------|--------|--------|------------------|--------|
|                                                       |   |              |   |   |             |   |
| Non-interest bearing short term funding from third parties |   |              | 16,599 |   |             |   | 15,730 |   |
|                                                       |   | $                 | 16,599 |   |             | $      | 15,730 |   |

| 2016   |   | $ | 76,240 |   |
|--------|--------|---|--------|--------|
|   |   | $ | 76,240 |   |

| - | equal to $20,000,000, payable as to an advance of $300,000 immediately after the loan agreement for the Kallo MobileCare and RuralCare program is signed by the Minister of Finance of the Republic of Guinea and the remainder within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. |
|---|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| - | equal to $4,000,000, payable within 7 to 14 business days of receipt of payment for the Project by Kallo in proportion to the payments received by Kallo. In addition, a performance incentive payment of $1,000,000 will be payable to three persons related to the third party in accordance to the same terms of payment described herein. |
|---|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| ITEM 2. | MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. |
|---------|----------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

| ITEM 3. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK. |
|---------|-------------------------------------------------------------|

| ITEM 4. | CONTROLS AND PROCEDURES. |
|---------|--------------------------|

| ITEM 1. | LEGAL PROCEEDINGS. |
|---------|--------------------|

| ITEM 1A. | RISK FACTORS. |
|----------|---------------|

----

Table of Contents

| ITEM 6. | EXHIBITS. |
|---------|-----------|

|    |                                                                                                         | Incorporated by reference | Filed    |
|---------|--------------------------------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                                         | Form                      | Date     | Number | herewith |
|    |                                                                                                         |                      |     |   |   |
| 2.1     | Articles of Merger                                                                                           | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.1     | Articles of Incorporation                                                                                    | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.2     | Bylaws                                                                                                       | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015)                                                               | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 4.1     | Specimen Stock Certificate                                                                                   | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.1    | Agreement with Rophe Medical Technologies Inc. dated December 11, 2009                                       | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.2    | Amended Agreement with Rophe Medical Technologies Inc. dated December 18, 2009                               | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.3    | Amended Agreement with Rophe Medical Technologies Inc. dated March 16, 2010                                  | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.4    | Investment Agreement with Kodiak Capital Group, LLC dated October 20, 2014                                   | S-1                       | 10/30/14 | 10.6 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.5    | Amended Agreement with Jarr Capital Corp.                                                                    | 8-K                       | 2/22/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.6    | Termination of Employment Agreement with John Cecil                                                          | 8-K                       | 2/22/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.7    | Termination of Employment Agreement with Vince Leitao                                                        | 8-K                       | 2/22/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.8    | Termination of Employment Agreement with Samuel Baker                                                        | 8-K                       | 2/22/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.9    | Services Agreement with Buchanan Associates Computer Consulting Ltd.                                         | 10-K                      | 5/18/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.10   | Equipment Lease Agreement with Buchanan Associates Computer Consulting Ltd.                                  | 10-K                      | 5/18/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.11   | Agreement with Mansfield Communications Inc.                                                                 | 10-K                      | 5/18/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.12   | Agreement with Watt International Inc.                                                                       | 10-K                      | 5/18/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.13   | Pilot EMR Agreement with Nexus Health Management Inc.                                                        | 10-K                      | 5/18/11  | 10.5 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.14   | 2011 Non-Qualified Stock Option Plan                                                                         | S-8                       | 6/27/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.15   | Multimedia Contractual Agreement with David Miller                                                           | 8-K                       | 10/28/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.16   | Strategic Alliance Agreement with Petro Data Management Services Limited and Gateway Global Fabrication Ltd. | 8-K                       | 11/02/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.17   | Independent Contractor Agreement with Savers Drug Mart                                                       | 8-K                       | 1/26/12  | 10.1 |   |

----

Table of Contents

|    |                                                                                                                                   |    |    |   |   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|---------|---------|--------|--------|
| 10.18   | 2012 Non-Qualified Stock Option Plan                                                                                                   | S-8     | 9/06/12 | 10.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.19   | Memorandum of Offering with Ministry of Health of Republic of Ghana                                                                    | S-1/A-3 | 6/26/13 | 10.32  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.20   | Addendum to Investment Agreement with Kodiak                                                                                           | S-1/A-4 | 7/31/13 | 10.33  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.21   | Second Addendum to Investment Agreement with Kodiak                                                                                    | S-1     | 8/25/14 | 10.34  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.22   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.35  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.23   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.36  |   |
|    |                                                                                                                                   |    |    |   |   |
| 14.1    | Code of Ethics                                                                                                                         | S-1     | 8/25/14 | 14.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.1    | Letter from Collins Barrow Toronto LLP                                                                                                 | 8-K/A-1 | 2/15/12 | 16.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.2    | Letter from Schwartz Levitsky Feldman LLP                                                                                              | 8-K/A-3 | 8/13/14 | 16.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 21.1    | List of Subsidiary Companies                                                                                                           | 10-K    | 3/31/10 | 21.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 31.1    | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 32.1    | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 99.1    | Audit Committee Charter                                                                                                                | 10-K    | 4/15/08 | 99.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.2    | Disclosure Committee Charter                                                                                                           | 10-K    | 4/15/08 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.3    | FCPA Code                                                                                                                              | S-1     | 8/25/14 | 99.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.4    | Letter from Ministry of Health                                                                                                         | 8-K     | 6/08/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.5    | Letter from Minister of Health and Public Hygiene                                                                                      | 8-K     | 6/24/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 101.INS | XBRL Instance Document                                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations                                                                                           |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions                                                                                            |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation                                                                                           |    |    |   | X      |

----

Table of Contents

|   | KALLO INC.         |
|--------|--------------------|
|   | (The "Registrant") |
|   |               |   |
|   | BY:                | JOHN CECIL |
|   |               | John Cecil |
|   |               | President, Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, and a Chairman of the Board of Directors |

----

Table of Contents

|    |                                                                                                         | Incorporated by reference | Filed    |
|---------|--------------------------------------------------------------------------------------------------------------|---------------------------|----------|
| Exhibit | Document Description                                                                                         | Form                      | Date     | Number | herewith |
|    |                                                                                                         |                      |     |   |   |
| 2.1     | Articles of Merger                                                                                           | 8-K                       | 1/21/11  | 2.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.1     | Articles of Incorporation                                                                                    | SB-2                      | 3/05/07  | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.2     | Bylaws                                                                                                       | SB-2                      | 3/05/07  | 3.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 3.3     | Amended Articles of Incorporation (11/23/2015)                                                               | 8-K                       | 12/02/15 | 3.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 4.1     | Specimen Stock Certificate                                                                                   | SB-2                      | 3/05/07  | 4.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.1    | Agreement with Rophe Medical Technologies Inc. dated December 11, 2009                                       | 10-K                      | 3/31/10  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.2    | Amended Agreement with Rophe Medical Technologies Inc. dated December 18, 2009                               | 10-K                      | 3/31/10  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.3    | Amended Agreement with Rophe Medical Technologies Inc. dated March 16, 2010                                  | 10-K                      | 3/31/10  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.4    | Investment Agreement with Kodiak Capital Group, LLC dated October 20, 2014                                   | S-1                       | 10/30/14 | 10.6 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.5    | Amended Agreement with Jarr Capital Corp.                                                                    | 8-K                       | 2/22/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.6    | Termination of Employment Agreement with John Cecil                                                          | 8-K                       | 2/22/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.7    | Termination of Employment Agreement with Vince Leitao                                                        | 8-K                       | 2/22/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.8    | Termination of Employment Agreement with Samuel Baker                                                        | 8-K                       | 2/22/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.9    | Services Agreement with Buchanan Associates Computer Consulting Ltd.                                         | 10-K                      | 5/18/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.10   | Equipment Lease Agreement with Buchanan Associates Computer Consulting Ltd.                                  | 10-K                      | 5/18/11  | 10.2 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.11   | Agreement with Mansfield Communications Inc.                                                                 | 10-K                      | 5/18/11  | 10.3 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.12   | Agreement with Watt International Inc.                                                                       | 10-K                      | 5/18/11  | 10.4 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.13   | Pilot EMR Agreement with Nexus Health Management Inc.                                                        | 10-K                      | 5/18/11  | 10.5 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.14   | 2011 Non-Qualified Stock Option Plan                                                                         | S-8                       | 6/27/11  | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.15   | Multimedia Contractual Agreement with David Miller                                                           | 8-K                       | 10/28/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.16   | Strategic Alliance Agreement with Petro Data Management Services Limited and Gateway Global Fabrication Ltd. | 8-K                       | 11/02/11 | 10.1 |   |
|    |                                                                                                         |                      |     |   |   |
| 10.17   | Independent Contractor Agreement with Savers Drug Mart                                                       | 8-K                       | 1/26/12  | 10.1 |   |

----

Table of Contents

|    |                                                                                                                                   |    |    |   |   |
|---------|----------------------------------------------------------------------------------------------------------------------------------------|---------|---------|--------|--------|
| 10.18   | 2012 Non-Qualified Stock Option Plan                                                                                                   | S-8     | 9/06/12 | 10.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.19   | Memorandum of Offering with Ministry of Health of Republic of Ghana                                                                    | S-1/A-3 | 6/26/13 | 10.32  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.20   | Addendum to Investment Agreement with Kodiak                                                                                           | S-1/A-4 | 7/31/13 | 10.33  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.21   | Second Addendum to Investment Agreement with Kodiak                                                                                    | S-1     | 8/25/14 | 10.34  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.22   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.35  |   |
|    |                                                                                                                                   |    |    |   |   |
| 10.23   | Email from Kodiak                                                                                                                      | S-1/A-1 | 9/24/14 | 10.36  |   |
|    |                                                                                                                                   |    |    |   |   |
| 14.1    | Code of Ethics                                                                                                                         | S-1     | 8/25/14 | 14.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.1    | Letter from Collins Barrow Toronto LLP                                                                                                 | 8-K/A-1 | 2/15/12 | 16.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 16.2    | Letter from Schwartz Levitsky Feldman LLP                                                                                              | 8-K/A-3 | 8/13/14 | 16.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 21.1    | List of Subsidiary Companies                                                                                                           | 10-K    | 3/31/10 | 21.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 31.1    | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 32.1    | Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002         |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 99.1    | Audit Committee Charter                                                                                                                | 10-K    | 4/15/08 | 99.1   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.2    | Disclosure Committee Charter                                                                                                           | 10-K    | 4/15/08 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.3    | FCPA Code                                                                                                                              | S-1     | 8/25/14 | 99.3   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.4    | Letter from Ministry of Health                                                                                                         | 8-K     | 6/08/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 99.5    | Letter from Minister of Health and Public Hygiene                                                                                      | 8-K     | 6/24/15 | 99.2   |   |
|    |                                                                                                                                   |    |    |   |   |
| 101.INS | XBRL Instance Document                                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.SCH | XBRL Taxonomy Extension – Schema                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.CAL | XBRL Taxonomy Extension – Calculations                                                                                           |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.DEF | XBRL Taxonomy Extension – Definitions                                                                                            |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.LAB | XBRL Taxonomy Extension – Labels                                                                                                 |    |    |   | X      |
|    |                                                                                                                                   |    |    |   |   |
| 101.PRE | XBRL Taxonomy Extension – Presentation                                                                                           |    |    |   | X      |